Researchers found that differences in the amount of key bacterial groups in the gut predicted cancer recurrence with up to 94 ...

Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...

Belinda Shipman told Newsweek that the monthlong treatment felt like her "face, body and mind were literally being torn apart ...

An international group led by researchers from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have ...

A new study revealed that differences in the amount of key bacterial groups in the gut accurately predicted cancer recurrence when patients were analyzed in a new way.

In my lowest moments, I'm always like, ‘oh, at least I can put on a good outfit,’” says the 26-year-old who shares her breast ...

Researchers with Diakonos Oncology are working to extend the lives of other patients diagnosed with other forms of cancer.

Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an ...

A medical oncologist called the late-stage clinical trial results “remarkable,” though Sasse said the drug means his body ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...